Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:286-289
doi: 10.1161/hs0102.101544
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ay, H.
Right arrow Articles by Saribas, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ay, H.
Right arrow Articles by Saribas, O.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Acute coronary syndromes
Right arrow Other diagnostic testing
Right arrow Acute myocardial infarction
Right arrow Acute Cerebral Infarction

(Stroke. 2002;33:286.)
© 2002 American Heart Association, Inc.


Research Reports

Creatine Kinase-MB Elevation After Stroke Is Not Cardiac in Origin

Comparison With Troponin T Levels

Hakan Ay, MD; Ethem Murat Arsava, MD Okay Saribas, MD

From the Department of Neurology, Hacettepe University Hospital, Ankara, Turkey.

Correspondence to Hakan Ay, MD, Hacettepe University Hospitals, Department of Neurology, Sihhiye 06100, Ankara-Turkey. E-mail ayhmgh{at}hotmail.com

Abstract

Background and Purpose Creatine kinase-MB (CK-MB) increases in some patients with stroke, with no clear evidence of an acute coronary syndrome. Its elevations have been suggested to represent a biological marker for stroke-related myocardial injury. Troponin T has superior sensitivity and specificity to CK-MB in revealing minor myocardial injury. Therefore, we studied troponin T levels after stroke to determine whether troponin T increases in parallel to CK-MB.

Methods We made daily measurements of CK-MB, myoglobin, total creatine kinase (total CK), and troponin T levels up to day 5 in 32 patients with large hemispheric infarction and with no history of coronary heart disease. The daily enzyme levels were compared with those of a control group of 22 patients with neurological diseases other than stroke.

Results Serum CK-MB, myoglobin, and total CK levels were elevated above the cutoff value in 11, 26, and 20 patients with stroke, respectively. These enzyme levels gradually increased within the first 3 days and declined afterward. Troponin T did not exceed the reference range in any patients. One patient had elevated myoglobin and 3 had elevated total CK in the control group. The difference between groups was significant for CK-MB, myoglobin, and total CK at various time points.

Conclusions Troponin T, a more specific biochemical marker of myocardial injury, does not increase after stroke. Normal troponin T along with elevated CK-MB signifies that CK-MB is not the biological marker for myocytolysis. CK-MB elevations in stroke patients are likely to be noncardiac in origin.


Key Words: creatine kinase-MB • myocardial infarction • stroke, ischemic • troponin T




This article has been cited by other articles:


Home page
Clin. Chem.Home page
W. E. Kelley, J. L. Januzzi, and R. H. Christenson
Increases of Cardiac Troponin in Conditions other than Acute Coronary Syndrome and Heart Failure
Clin. Chem., December 1, 2009; 55(12): 2098 - 2112.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. M. Sugg, N. R. Gonzales, D. E. Matherne, M. Ribo, H. M. Shaltoni, S. Baraniuk, E. A. Noser, and J. C. Grotta
Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
Neurology, September 26, 2006; 67(6): 1053 - 1055.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Ay, W. J. Koroshetz, T. Benner, M. G. Vangel, C. Melinosky, E. M. Arsava, C. Ayata, M. Zhu, L. H. Schwamm, and A. G. Sorensen
Neuroanatomic correlates of stroke-related myocardial injury
Neurology, May 9, 2006; 66(9): 1325 - 1329.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. Anderson
Candidate-based proteomics in the search for biomarkers of cardiovascular disease
J. Physiol., February 15, 2005; 563(1): 23 - 60.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Etgen, H. Baum, K. Sander, and D. Sander
Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide in Acute Ischemic Stroke Do Not Relate to Clinical Prognosis
Stroke, February 1, 2005; 36(2): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Dittmar, T. Spruss, G. Schuierer, and M. Horn
External Carotid Artery Territory Ischemia Impairs Outcome in the Endovascular Filament Model of Middle Cerebral Artery Occlusion in Rats
Stroke, September 1, 2003; 34(9): 2252 - 2257.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. S. Butcher, M. W. Parsons, H. Ay, E. M. Arsava, and O. Saribas
Cardiac Enzyme Elevations After Stroke: The Importance of Specificity * Response
Stroke, August 1, 2002; 33(8): 1944 - 1945.
[Full Text] [PDF]